Association between claims‐based setting of diagnosis and treatment initiation among Medicare patients with hepatitis C

Hao Zhang,Yuhua Bao,Kayla Hutchings,Martin F. Shapiro,Shashi N. Kapadia

DOI: https://doi.org/10.1111/1475-6773.14330

2024-05-23

Health Services Research

Abstract:Objective To develop a claims‐based algorithm to determine the setting of a disease diagnosis. Data Sources and Study Setting Medicare enrollment and claims data from 2014 to 2019. Study Design We developed a claims‐based algorithm using facility indicators, revenue center codes, and place of service codes to identify settings where HCV diagnosis first appeared. When the first appearance was in a laboratory, we attempted to associate HCV diagnoses with subsequent clinical visits. Face validity was assessed by examining association of claims‐based diagnostic settings with treatment initiation. Data Collection/Extraction Methods Patients newly diagnosed with HCV and continuously enrolled in traditional Medicare Parts A, B, and D (12 months before and 6 months after index diagnosis) were included. Principal Findings Among 104,454 patients aged 18–64 and 66,726 aged ≥65, 70.1% and 69%, respectively, were diagnosed in outpatient settings, and 20.2% and 22.7%, respectively in laboratory or unknown settings. Logistic regression revealed significantly lower odds of treatment initiation after diagnosis in emergency departments/urgent cares, hospitals, laboratories, or unclassified settings, than in outpatient visits. Conclusions The algorithm identified the setting of HCV diagnosis in most cases, and found significant associations with treatment initiation, suggesting an approach that can be adapted for future claims‐based studies.

health care sciences & services,health policy & services